Space Exploration Medical Evacuation Risk Assessments: A Qualitative Investigation
Explore the source record for details and available documents.
SEARCH · Engineering Papers
Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Explore the source record for details and available documents.
Surface thermal features, most notably hot springs and geysers are increasingly being recognized for their importance to ecosystems, indigenous cultures, and in some cases agriculture, recreation, and tourism. Geothermal project development poses a potential risk to these natural features but current regulatory requirements for assessing and managing these risks during exploration, permitting and monitoring are somewhat inconsistent and unpredictable across different geothermal fields. This has resulted in uncertainty and increases in exploration risk for geothermal energy developers that have led to costly project delays, cancellations, or hesitation to commit. Varying regulatory requirements may also influence public perception, fostering confusion, distrust and ultimately opposition to geothermal projects, further contributing to project delays or cancellations. At a time when there is an increasing urgency for reliable baseload clean energy, geothermal is a net-zero, renewable solution that additionally provides access to more equitable and environmentally just clean power. Continued integration of geothermal energy into the national energy roadmap can be facilitated through consistent and predictable permitting, providing regulators the framework they need, developers a clear path forward, and transparency that the public deserves. This project, currently in its beginning phases, seeks to address this important issue by providing a technical basis from which to build a preliminary protocol for assessing and managing potential impacts from new or existing geothermal energy projects to surface thermal features and their associated ecosystems. Development of this preliminary protocol will be informed by (1) a literature review of well-documented case studies in the western U.S. and New Zealand to understand the range of conditions that exemplify geothermal-surface thermal systems; (2) development of generic illustrative conceptual-numerical models to quantify, understand, and predict the first-order controls (e.g., pressure and permeability) on surface flows; and (3) additional independent and scientifically rigorous evaluations of geothermal-surface thermal system case studies from the Basin and Range Province that incorporate publicly available data as well as data provided by industry through data-sharing agreements. Learning from the successes of the process used to develop the Induced Seismicity Management Protocol (ISMP), we ultimately aim to use these initial efforts as a springboard for establishing a surface thermal feature management working group that will work collaboratively to finalize the protocol as well as co-create recommended best practices for implementation. We envision that the working group will primarily be composed of representatives from regulatory entities, government agencies, Tribes, academia, national laboratories, and industry, and will include early and regular engagement with community organizations and environmental groups. This will help ensure broad acceptance and implementation of the protocol, which will facilitate a more consistent, predictable, and standardized regulatory process, and help to ensure that geothermal energy continues to provide a reliable source of clean energy, and a pathway to achieving greater energy equity in the U.S.
Exposures from galactic cosmic rays (GCR) - made up of high-energy protons and high-energy and charge (HZE) nuclei, and solar particle events (SPEs) - comprised largely of low- to medium-energy protons are the primary health concern for astronauts for long-term space missions. Experimental studies have shown that HZE nuclei produce both qualitative and quantitative differences in biological effects compared to terrestrial radiation, making risk assessments for cancer and degenerative risks, such as central nervous system effects and heart disease, highly uncertain. The goal for space radiation protection at NASA is to be able to reduce the uncertainties in risk assessments for Mars exploration to be small enough to ensure acceptable levels of risks are not exceeded and to adequately assess the efficacy of mitigation measures such as shielding or biological countermeasures. We review the recent BEIR VII and UNSCEAR-2006 models of cancer risks and their uncertainties. These models are shown to have an inherent 2-fold uncertainty as defined by ratio of the 95% percent confidence level to the mean projection, even before radiation quality is considered. In order to overcome the uncertainties in these models, new approaches to risk assessment are warranted. We consider new computational biology approaches to modeling cancer risks. A basic program of research that includes stochastic descriptions of the physics and chemistry of radiation tracks and biochemistry of metabolic pathways, to emerging biological understanding of cellular and tissue modifications leading to cancer is described.
A well-known hazard associated with exposure to the space environment is the risk of failure due to an impact from a micrometeoroid and orbital debris (MMOD) particle. As NASA prepares to return astronauts to the moon with the Artemis program, the next generation of spacesuit is in development to support future extravehicular activities (EVAs). An MMOD impact to the spacesuit is of great concern as a large leak could prevent an astronaut from safely reaching an airlock in time resulting in a loss of life. The exploration extravehicular mobility unit (xEMU) must meet MMOD requirements for multiple environments including those in low earth orbit (LEO) as well as the meteoroid and secondary lunar regolith ejecta environments found on the lunar surface. The subject of this paper is an MMOD risk assessment of the internal xEMU configuration design developed by NASA Johnson Space Center (JSC) personnel. Assessment of the MMOD risk for an 8-hour, 2-person EVA in both LEO and on the lunar surface showed that the xEMU spacesuit meets the program technical requirement of 1 in 2500 failure odds.
We propose an ESA Flexi Mission, LUGH, Mercury Express Mission, an extremely fast, low cost, low risk, high return, three-platform, multiple flyby mission which would provide data which are unique and complimentary to recently selected long lead time Mercury missions.
A well-known hazard associated with exposure to the space environment is the risk of failure due to an impact from a micrometeoroid and orbital debris (MMOD) particle. As NASA prepares to return astronauts to the moon with the Artemis program, the next generation of spacesuit is in development to support future extravehicular activities (EVAs.) An MMOD impact to the spacesuit is of great concern as a large leak could prevent an astronaut from safely reaching an airlock in time resulting in a loss of life. The exploration extravehicular mobility unit (xEMU) must meet MMOD requirements for multiple environments including those in low earth orbit (LEO) as well as the meteoroid and secondary lunar regolith ejecta environments found on the lunar surface. The subject of this paper is an internal xEMU configuration design developed by NASA Johnson Space Center (JSC) personnel. The xEMU shares similarities with the legacy Extravehicular Mobility Unit (EMU) spacesuit that is currently used for ISS EVAs, however differences in the layup (e.g., materials, thicknesses, and layers) of the fabric environmental protection garment (EPG), portable life support system (xPLSS) and helmet required an extensive test program to determine ballistic performance. Over 100 hypervelocity impact (HVI) tests were performed by the NASA/JSC HVIT and White Sands Test Facility (WSTF) teams on the xEMU EPG, xPLSS and helmet to generate ballistic limit equations (BLEs) for MMOD impacts. Additionally, over 50 low speed tests (< 1km/s) were performed by the NASA/JSC HVIT and Southwest Research Institute (SwRI) teams on the xEMU EPG, xPLSS and helmet to generate BLEs for lunar ejecta impacts. Post testing, ballistic limit equations (BLEs) used to define the performance of the various regions on the xEMU spacesuit were developed from a generic set of BLEs. The HVI and low speed testing was performed to establish a physical basis for the equations with the coefficients and exponents of the generic BLEs adjusted to fit the test data. The xEMU BLEs were added to the NASA/JSC software application used for spacecraft MMOD risk assessments (BUMPER-3). A finite element model (FEM) of the xEMU spacesuit, which defines the size and shape of the spacesuit as well as the locations of the various shielding configurations, was created based on a solid model provided by the xEMU program office. Using the FEM file and added xEMU BLEs, BUMPER-3 assessments of the xEMU spacesuit for probability of no penetration (PNP) were performed. For the LEO assessment of a typical ISS EVA, the orbital debris and meteoroids environments were defined using the latest engineering models, ORDEM 3.2 and MEM-3 respectively. The lunar surface assessment again used the MEM-3 engineering model to define the meteoroid environment along with the current released lunar surface ejecta model, NASA SP-8013 (developed during the Apollo Program). The Space Team in the Natural Environments Branch at Marshall Space Flight Center (MSFC) will soon release the new Lunar Meteoroid Ejecta Engineering Model (LMEEM), at which time the xEMU lunar surface EVA will be reassessed. Assessment of the MMOD risk for an 8-hour, 2-person EVA in both LEO and on the lunar surface showed that the xEMU spacesuit meets the program technical requirement of 1 in 2500 failure odds. Similar to the legacy EMU spacesuit, the majority of the MMOD risk (96% of the LEO EVA risk and 99% of the lunar surface EVA risk) is concentrated in regions of xEMU that are comprised primarily of softgoods (arms, legs, and gloves) rather than the hardgoods (xPLSS, hard upper torso and helmet).
A well-known hazard associated with exposure to the space environment is the risk of failure due to an impact from a micrometeoroid and orbital debris (MMOD) particle. As NASA prepares to return astronauts to the moon with the Artemis program, the next generation of spacesuit is in development to support future extravehicular activities (EVAs.) An MMOD impact to the spacesuit is of great concern as a large leak could prevent an astronaut from safely reaching an airlock in time resulting in a loss of life. The exploration extravehicular mobility unit (xEMU) must meet MMOD requirements for multiple environments including those in low earth orbit (LEO) as well as the meteoroid and secondary lunar regolith ejecta environments found on the lunar surface. The subject of this paper is an internal xEMU configuration design developed by NASA Johnson Space Center (JSC) personnel. This paper will expand on the hypervelocity impact (HVI) testing and ballistic limit equation (BLE) definition work that was partially presented at the 2nd International Orbital De-bris (IOC-II) Conference held in Sugar Land, TX in December 2023. The xEMU shares similarities with the legacy Extravehicular Mobility Unit (EMU) spacesuit that is currently used for ISS EVAs, however differences in the layup (e.g., materials, thicknesses, and layers) of the fabric environmental protection garment (EPG), portable life support system (xPLSS) and helmet required an extensive test program to determine ballistic performance. Over 100 hypervelocity impact (HVI) tests were performed by the NASA/JSC HVIT and White Sands Test Facility (WSTF) teams on the xEMU EPG, xPLSS and helmet to generate ballistic limit equations (BLEs) for MMOD impacts. Additionally, over 50 low speed tests (< 1km/s) were performed by the NASA/JSC HVIT and Southwest Research Institute (SwRI) teams on the xEMU EPG, xPLSS and helmet to generate BLEs for lunar ejecta impacts. Post testing, ballistic limit equations used to define the performance of the various regions on the xEMU spacesuit were developed from a generic set of BLEs. The HVI and low speed testing was performed to establish a physical basis for the equations with the co-efficients and exponents of the generic BLEs adjusted to fit the test data. The xEMU BLEs were added to the NASA/JSC software application used for space-craft MMOD risk assessments (BUMPER-3). A finite element model (FEM) of the xEMU spacesuit, which defines the size and shape of the spacesuit as well as the locations of the various shielding configurations, was created based on a solid model provided by the xEMU program office. Using the FEM file and added xEMU BLEs, BUMPER-3 assessments of the xEMU spacesuit for probability of no penetration (PNP) were performed. For the LEO assessment of a typical ISS EVA, the orbital debris and meteoroids environments were defined using the latest engineering models, ORDEM 3.2 and MEM-3 respectively. The lunar sur-face assessment again used the MEM-3 engineering model to define the meteoroid environ-ment along with the current released lunar surface ejecta model, NASA SP-8013 (developed during the Apollo Program). The Space Team in the Natural Environments Branch at Mar-shall Space Flight Center (MSFC) will soon release the new Lunar Meteoroid Ejecta Engineering Model (LMEEM), at which time the xEMU lunar surface EVA will be reassessed. Assessment of the MMOD risk for an 8-hour, 2-person EVA in both LEO and on the lunar surface showed that the xEMU spacesuit meets the program technical requirement of 1 in 2500 failure odds. Similar to the legacy EMU spacesuit, the majority of the MMOD risk (96% of the LEO EVA risk and 99% of the lunar surface EVA risk) is concentrated in regions of xEMU that are comprised primarily of softgoods (arms, legs, and gloves) rather than the hardgoods (xPLSS, hard upper torso and helmet).
Large-scale deployment of Carbon Capture and Storage (CCS) will require a commensurately large number of sites. Efficient screening methods are needed to create investment assurance and focus efforts on the most promising sites. The problem is similar to petroleum exploration, for which there are well-developed (though seldom published) workflows, including Common Risk Segment (CRS) mapping. In brief, the process requires 1) defining the key play elements; 2) identifying candidate geologic intervals for each; 3) creating fact-based maps for those intervals; 4) determining minimum criteria for the success of each element; 5) reinterpreting the fact-based maps in terms of chance of success; and 6) combining the individual maps to form a composite, basin-scale view of prospectivity. We adapt the CRS process to screening for CO 2 storage sites. Critically, we redefine the process in terms of cost of characterization and development, rather than chance of success. For illustration, we apply the process to the example of the Lower Miocene on the Texas and Louisiana Gulf Coast. We show that the predictions are consistent with historic hydrocarbon production volumes and rates. The power of the CRS method is that it creates a systematic approach to geologic evaluation and translates complex, multidimensional analysis into clear, graphical and easily comprehended business inputs. The results highlight sweet spots and identifies critical risks, suggesting a focus for further data collection and analysis. Furthermore, the method developed here can be applied to both surface and subsurface factors anywhere that there is interest in geologic storage of CO 2 .
BACKGROUND: Within NASA’s Human Research Program, the Exploration Medical Capability (ExMC) Element has three primary focus areas: clinical and scientific research, systems engineering and trade space analysis, and technology development and demonstrations. These focus areas feed into the overarching goal of enabling progressively Earth-Independent Medical Operations (EIMO), a new paradigm that will be necessary for future Artemis and Mars medical and vehicle systems. This EIMO end state aligns with NASA’s Moon to Mars Objectives, which clearly outline the need for NASA deep space exploration missions to reduce their reliance upon Earth and become increasingly autonomous, in preparation for the first human Mars mission. OVERVIEW: To advance exploration medical systems and ultimately, integrated crew health and performance systems, ExMC’s portfolio includes: funding ground development & testing of novel medical capabilities; creation of new approaches for the development of medical protocols and procedures; deployment of innovative technologies into analog environments; technology demonstrations in spaceflight; and eventual transition to operations of new capabilities for deep space exploration missions. The portfolio also includes: pharmaceutical research targeting stability, pharmacokinetics, and pharmacodynamics; integrated data architectures and clinical decision support tools; and systems engineering and trade space analysis tools to assist NASA in the development of future medical system models as well as the medical system requirements that can serve as a foundation for deep space exploration missions. All of these investments are done in a collaborative and coordinated fashion with other NASA stakeholders, such as the Environmental Control and Life Support Systems – Crew Health and Performance System Capability Leadership Team and the Health and Medical Technical Authority. DISCUSSION: In this presentation, ExMC will provide an overview of our work from across our portfolio, all of which will inform future EIMO efforts at NASA. ExMC’s research and development investments are targeted to reduce the human system risks associated with deep space exploration to the Moon and Mars.
Spirometry-based studies of occupational lung disease have mostly focused on obstructive or mixed obstructive/restrictive outcomes. We wanted to determine if restrictive spirometry pattern (RSP) is associated with occupation and increased mortality. Study participants included 18,145 workers with demographic and smoking data and repeatable spirometry. The mortality analysis cohort included 15,445 workers with known vital status and cause of death through December 31, 2016. Stratified analyses explored RSP prevalence by demographic and clinical variables and trade. Log-binomial regression models explored RSP risk factors while controlling for important confounders such as smoking, obesity, and comorbidities. Cox regression models explored mortality risk by spirometry category. Prevalence of RSP was very high (28.6%). Mortality hazard ratios for RSP were 1.50 for all causes, 1.86 for cardiovascular diseases, 2.31 for respiratory diseases, and 1.66 for lung cancer. All construction trades except painters, machinists, and roofers had significantly elevated risk for RSP compared to our internal reference group. RSP was significantly associated with both parenchymal and pleural changes seen by chest X-ray. Construction trade workers are at significantly increased risk for RSP independent of obesity. Individuals with RSP are at increased risk for all-cause mortality as well as mortality attributable to respiratory diseases, cardiovascular diseases, and lung cancer. RSP deserves greater attention in occupational medicine and epidemiology.
Radiation protection is essential to enable humans to live and work safely in space. Predictions about the nature and magnitude of the risks posed by space radiation are subject to very large uncertainties. Prudent use of worst-case scenarios may impose unacceptable constraints on shielding mass for spacecraft or habitats, tours of duty of crews on Space Station, and on the radius and duration of sorties on planetary surfaces. The NASA Space Radiation Health Program has been devised to develop the knowledge required to accurately predict and to efficiently manage radiation risk. The knowledge will be acquired by means of a peer-reviewed, largely ground-based and investigator-initiated, basic science research program. The NASA Strategic Plan to accomplish these objectives in a manner consistent with the high priority assigned to the protection and health maintenance of crews will be presented. Published by Elsevier Science Ltd on behalf of COSPAR.
NASA is contemplating future human exploration missions to destinations beyond low Earth orbit, including the Moon, deep-space asteroids, and Mars. While we have learned much about protecting crew health and performance during orbital space flight over the past half-century, the challenges of these future missions far exceed those within our current experience base. To ensure success in these missions, we have developed a Human System Risk Board (HSRB) to identify, quantify, and develop mitigation plans for the extraordinary risks associated with each potential mission scenario. The HSRB comprises research, technology, and operations experts in medicine, physiology, psychology, human factors, radiation, toxicology, microbiology, pharmacology, and food sciences. Methods: Owing to the wide range of potential mission characteristics, we first identified the hazards to human health and performance common to all exploration missions: altered gravity, isolation/confinement, increased radiation, distance from Earth, and hostile/closed environment. Each hazard leads to a set of risks to crew health and/or performance. For example the radiation hazard leads to risks of acute radiation syndrome, central nervous system dysfunction, soft tissue degeneration, and carcinogenesis. Some of these risks (e.g., acute radiation syndrome) could affect crew health or performance during the mission, while others (e.g., carcinogenesis) would more likely affect the crewmember well after the mission ends. We next defined a set of design reference missions (DRM) that would span the range of exploration missions currently under consideration. In addition to standard (6-month) and long-duration (1-year) missions in low Earth orbit (LEO), these DRM include deep space sortie missions of 1 month duration, lunar orbital and landing missions of 1 year duration, deep space journey and asteroid landing missions of 1 year duration, and Mars orbital and landing missions of 3 years duration. We then assessed the likelihood and consequences of each risk against each DRM, using three levels of likelihood (Low: less than or equal to 0.1%; Medium: 0.1%–1.0%; High: greater than or equal to 1.0%) and four levels of consequence ranging from Very Low (temporary or insignificant) to High (death, loss of mission, or significant reduction to length or quality of life). Quantitative evidence from clinical, operational, and research sources were used whenever available. Qualitative evidence was used when quantitative evidence was unavailable. Expert opinion was used whenever insufficient evidence was available. Results: A set of 30 risks emerged that will require further mitigation efforts before being accepted by the Agency. The likelihood by consequence risk assessment process provided a means of prioritizing among the risks identified. For each of the high priority risks, a plan was developed to perform research, technology, or standards development thought necessary to provide suitable reduction of likelihood or consequence to allow agency acceptance. Conclusion: The HSRB process has successfully identified a complete set of risks to human space travelers on planned exploration missions based on the best evidence available today. Risk mitigation plans have been established for the highest priority risks. Each risk will be reassessed annually to track the progress of our risk mitigation efforts.
Probabilistic risk assessment (PRA) is a method for assessing and integrating the risk of failure in a multivariate system. While it is often applied by engineers designing complex machines, it could also be applied to humans to assess the probability of a health “failure” treating diseases as the multiple “variables” and the human as the “complex machine.” The Medical Extensible Dynamic Probabilistic Risk Assessment Tool (MEDPRAT) was developed to apply PRA to assess medical risk for exploration spaceflight and inform the design of medical systems for space flight. The NASA engineering community utilizes event-driven and fault tree probabilistic techniques to classify risk in the space flight environment by leveraging the inherent knowledge of complex space flight system design and testing to quantify risk. However, in harmonizing the risk of human space flight, answering the question of “How do we balance astronaut health, performance and resource risks with other engineering risks on exploration space missions?” remains a profoundly challenging and largely qualitative practice. The Medical Extensible Dynamic Probabilistic Risk Assessment Tool (MEDPRAT) is one aspect of the Human Research Program’s efforts to represent space fight human health and performance risks quantitatively.
The impetus for asteroid exploration is scientific, political, and pragmatic. The notion of sending human explorers to asteroids is not new. Piloted missions to these primitive bodies were first discussed in the 1960s, pairing Saturn V rockets with enhanced Apollo spacecraft to explore what were then called "Earth-approaching asteroids." Two decades ago, NASA's Space Exploration Initiative (SEI) also briefly examined the possibility of visiting these small celestial bodies. Most recently, the U.S. Human Space Flight Review Committee (the second Augustine Commission) suggested that near-Earth objects (NEOs) represent a target-rich environment for exploration via the "Flexible Path" option. However, prior to seriously considering human missions to NEOs, it has become clear that we currently lack a robust catalog of human accessible targets. The majority of the NEOs identified by a study team across several NASA centers as "human-accessible" are probably too small and have orbits that are too uncertain to consider mounting piloted expeditions to these small worlds. The first step in developing such a catalog is, therefore, to complete a space-based NEO survey. The resulting catalog of candidate NEOs would then be transformed into a matrix of opportunities for robotic and human missions for the next several decades. This initial step of a space-based NEO survey first is the linchpin to laying the foundation of a low-risk architecture to venture out and explore these primitive bodies. We suggest such a minimalist framework architecture from 1) extensive ground-based and precursor spacecraft investigations (while applying operational knowledge from science-driven robotic missions), 2) astronaut servicing of spacecraft operating at geosynchronous Earth orbit to retain essential skills and experience, and 3) applying the sum of these skills, knowledge and experience to piloted missions to NEOs.
Space radiation presents major challenges to future missions to the Earth s moon or Mars. Health risks of concern include cancer, degenerative and performance risks to the central nervous system, heart and lens, and the acute radiation syndromes. The galactic cosmic rays (GCR) contain high energy and charge (HZE) nuclei, which have been shown to cause qualitatively distinct biological damage compared to terresterial radiation, such as X-rays or gamma-rays, causing risk estimates to be highly uncertain. The biological effects of solar particle events (SPE) are similar to terresterial radiation except for their biological dose-rate modifiers; however the onset and size of SPEs are difficult to predict. The high energies of GCR reduce the effectiveness of shielding, while SPE s can be shielded however the current gap in radiobiological knowledge hinders optimization. Methods used to project risks on Earth must be modified because of the large uncertainties in projecting health risks from space radiation, and thus impact mission requirements and costs. We describe NASA s unique approach to radiation safety that applies probabilistic risk assessments and uncertainty based criteria within the occupational health program for astronauts and to mission design. The two terrestrial criteria of a point estimate of maximum acceptable level of risk and application of the principle of As Low As Reasonably Achievable (ALARA) are supplemented by a third requirement that protects against risk projection uncertainties using the upper 95% confidence level (CL) in radiation risk projection models. Exploration science goals in radiation protection are centered on ground-based research to achieve the necessary biological knowledge, and in the development of new technologies to improve SPE monitoring and optimize shielding. Radiobiology research is centered on a ground based program investigating the radiobiology of high-energy protons and HZE nuclei at the NASA Space Radiation Laboratory (NSRL) located at DoE s Brookhaven National Laboratory in Upton, NY. We describe recent NSRL results that are closing the knowledge gap in HZE radiobiology and improving exploration risk estimates. Linking probabilistic risk assessment to research goals makes it possible to express risk management objectives in terms of quantitative metrics, which include the number of days in space without exceeding a given risk level within well defined confidence limits, and probabilistic assessments of the effectiveness of design trade spaces such as material type, mass, solar cycle, crew selection criteria, and biological countermeasures. New research in SPE alert and risk assessment, individual radiation sensitivity, and biological countermeasure development are described.
In January, 2004, the U.S. President announced The Vision for Space Exploration, and charged the National Aeronautics and Space Administration (NASA) with using the International Space Station (ISS) for research and technology targeted at supporting U.S. space exploration goals. This paper describes: What we have learned from the first four years of research on ISS relative to the exploration mission; The on-going research being conducted in this regard; and Our current understanding of the major exploration mission risks that the ISS can be used to address. Specifically, we discuss research carried out on the ISS to determine the mechanisms by which human health is affected on long-duration missions, and to develop countermeasures to protect humans from the space environment. These bioastronautics experiments are key enablers of future long duration human exploration missions. We also discuss how targeted technological developments can enable mission design trade studies. We discuss the relationship between the ultimate number of human test subjects available on the ISS to the quality and quantity of scientific insight that can be used to reduce health risks to future explorers. We discuss the results of NASA's efforts over the past year to realign the ISS research programs to support a product-driven portfolio that is directed towards reducing the major risks of exploration missions. The fundamental challenge to science on ISS is completing experiments that answer key questions in time to shape design decisions for future exploration. In this context, exploration relevant research must do more than be conceptually connected to design decisions - it must become a part of the mission design process.
The Integrated Medical Model (IMM) captures organizational knowledge across the space medicine, training, operations, engineering, and research domains. IMM uses this knowledge in the context of a mission and crew profile to forecast risks to crew health and mission success. The IMM establishes a quantified, statistical relationship among medical conditions, risk factors, available medical resources, and crew health and mission outcomes. These relationships may provide an appropriate foundation for developing an in-flight medical decision support tool that helps optimize the use of medical resources and assists in overall crew health management by an autonomous crew with extremely limited interactions with ground support personnel and no chance of resupply.
A concern for long-term space travel outside the Earth s magnetic field is the late effects to the central nervous system (CNS) from galactic cosmic ray (GCR) or solar particle events (SPE). Human epidemiology data is severely limited for making CNS risk estimates and it is not clear such effects occur following low LET exposures. We are developing systems biology models based on biological information on specific diseases, and experimental data for proton and heavy ion radiation. A two-hit model of Alzheimer s disease (AD) has been proposed by Zhu et al.(1), which is the framework of our model. Of importance is that over 50% of the US population over the age of 75-y have mild to severe forms of AD. Therefore we recommend that risk assessment for a potential AD risk from space radiation should focus on the projection of an earlier age of onset of AD and the prevention of this possible acceleration through countermeasures. In the two-hit model, oxidative stress and aberrant cell cycle-related abnormalities leading to amyloid-beta plaques and neurofibrillary tangles are necessary and invariant steps in AD. We have formulated a stochastic cell kinetics model of the two-hit AD model. In our model a population of neuronal cells is allowed to undergo renewal through neurogenesis and is susceptible to oxidative stress or cell cycle abnormalities with age-specific accumulation of damage. Baseline rates are fitted to AD population data for specific ages, gender, and for persons with an apolipoprotein 4 allele. We then explore how low LET or heavy ions may increase either of the two-hits or neurogenesis either through persistent oxidative stress, direct mutation, or through changes to the micro-environment, and suggest possible ways to develop accurate quantitative estimates of these processes for predicting AD risks following long-term space travel.